nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—Timolol—CYP2D6—breast cancer	0.0024	0.183	CrCbGaD
Penbutolol—Carteolol—CYP2D6—breast cancer	0.00214	0.163	CrCbGaD
Penbutolol—Timolol—ABCB1—breast cancer	0.00171	0.131	CrCbGaD
Penbutolol—Headache—Exemestane—breast cancer	0.00166	0.002	CcSEcCtD
Penbutolol—Dizziness—Ixabepilone—breast cancer	0.00166	0.00199	CcSEcCtD
Penbutolol—Amnesia—Capecitabine—breast cancer	0.00165	0.00199	CcSEcCtD
Penbutolol—Cough—Goserelin—breast cancer	0.00165	0.00198	CcSEcCtD
Penbutolol—Alopecia—Thiotepa—breast cancer	0.00164	0.00197	CcSEcCtD
Penbutolol—Bradycardia—Irinotecan—breast cancer	0.00163	0.00196	CcSEcCtD
Penbutolol—Bradycardia—Mitoxantrone—breast cancer	0.00163	0.00196	CcSEcCtD
Penbutolol—Agranulocytosis—Gemcitabine—breast cancer	0.00162	0.00195	CcSEcCtD
Penbutolol—Diarrhoea—Letrozole—breast cancer	0.00161	0.00194	CcSEcCtD
Penbutolol—Diarrhoea—Anastrozole—breast cancer	0.00161	0.00194	CcSEcCtD
Penbutolol—Dyspepsia—Chlorambucil—breast cancer	0.0016	0.00192	CcSEcCtD
Penbutolol—Agranulocytosis—Fluorouracil—breast cancer	0.0016	0.00192	CcSEcCtD
Penbutolol—Nausea—Exemestane—breast cancer	0.00158	0.0019	CcSEcCtD
Penbutolol—Headache—Ixabepilone—breast cancer	0.00157	0.00189	CcSEcCtD
Penbutolol—Fatigue—Chlorambucil—breast cancer	0.00156	0.00188	CcSEcCtD
Penbutolol—Hyperhidrosis—Tamoxifen—breast cancer	0.00156	0.00188	CcSEcCtD
Penbutolol—Dizziness—Anastrozole—breast cancer	0.00156	0.00188	CcSEcCtD
Penbutolol—Dizziness—Letrozole—breast cancer	0.00156	0.00188	CcSEcCtD
Penbutolol—Pain—Chlorambucil—breast cancer	0.00155	0.00187	CcSEcCtD
Penbutolol—Atrioventricular block—Epirubicin—breast cancer	0.00154	0.00185	CcSEcCtD
Penbutolol—Diarrhoea—Raloxifene—breast cancer	0.00153	0.00184	CcSEcCtD
Penbutolol—Diarrhoea—Idarubicin—breast cancer	0.00153	0.00184	CcSEcCtD
Penbutolol—Oxprenolol—CYP2D6—breast cancer	0.00152	0.116	CrCbGaD
Penbutolol—Upper respiratory tract infection—Paclitaxel—breast cancer	0.00152	0.00183	CcSEcCtD
Penbutolol—Hyperhidrosis—Goserelin—breast cancer	0.00149	0.00179	CcSEcCtD
Penbutolol—Nausea—Ixabepilone—breast cancer	0.00149	0.00179	CcSEcCtD
Penbutolol—Dizziness—Raloxifene—breast cancer	0.00148	0.00178	CcSEcCtD
Penbutolol—Headache—Letrozole—breast cancer	0.00148	0.00178	CcSEcCtD
Penbutolol—Headache—Anastrozole—breast cancer	0.00148	0.00178	CcSEcCtD
Penbutolol—Cough—Vinorelbine—breast cancer	0.00148	0.00178	CcSEcCtD
Penbutolol—Mood swings—Capecitabine—breast cancer	0.00147	0.00177	CcSEcCtD
Penbutolol—Insomnia—Tamoxifen—breast cancer	0.00146	0.00176	CcSEcCtD
Penbutolol—Depression—Paclitaxel—breast cancer	0.00145	0.00175	CcSEcCtD
Penbutolol—Dyspnoea—Tamoxifen—breast cancer	0.00144	0.00173	CcSEcCtD
Penbutolol—Body temperature increased—Chlorambucil—breast cancer	0.00143	0.00172	CcSEcCtD
Penbutolol—Pain—Vinblastine—breast cancer	0.00142	0.00171	CcSEcCtD
Penbutolol—Dyspepsia—Tamoxifen—breast cancer	0.00142	0.00171	CcSEcCtD
Penbutolol—Atrioventricular block—Doxorubicin—breast cancer	0.00142	0.00171	CcSEcCtD
Penbutolol—Alopecia—Mitoxantrone—breast cancer	0.00142	0.0017	CcSEcCtD
Penbutolol—Alopecia—Irinotecan—breast cancer	0.00142	0.0017	CcSEcCtD
Penbutolol—Cough—Thiotepa—breast cancer	0.00141	0.0017	CcSEcCtD
Penbutolol—Dyspnoea—Melphalan—breast cancer	0.00141	0.0017	CcSEcCtD
Penbutolol—Headache—Raloxifene—breast cancer	0.0014	0.00169	CcSEcCtD
Penbutolol—Headache—Idarubicin—breast cancer	0.0014	0.00169	CcSEcCtD
Penbutolol—Nausea—Anastrozole—breast cancer	0.0014	0.00169	CcSEcCtD
Penbutolol—Nausea—Letrozole—breast cancer	0.0014	0.00169	CcSEcCtD
Penbutolol—Insomnia—Goserelin—breast cancer	0.0014	0.00168	CcSEcCtD
Penbutolol—Fatigue—Tamoxifen—breast cancer	0.00139	0.00167	CcSEcCtD
Penbutolol—Dyspepsia—Melphalan—breast cancer	0.00139	0.00167	CcSEcCtD
Penbutolol—Alprenolol—CYP2D6—breast cancer	0.00139	0.106	CrCbGaD
Penbutolol—Pain—Tamoxifen—breast cancer	0.00138	0.00166	CcSEcCtD
Penbutolol—Alopecia—Gemcitabine—breast cancer	0.00138	0.00166	CcSEcCtD
Penbutolol—Dyspnoea—Goserelin—breast cancer	0.00138	0.00165	CcSEcCtD
Penbutolol—Fatigue—Melphalan—breast cancer	0.00136	0.00164	CcSEcCtD
Penbutolol—Nadolol—ABCB1—breast cancer	0.00136	0.104	CrCbGaD
Penbutolol—Dyspepsia—Goserelin—breast cancer	0.00136	0.00163	CcSEcCtD
Penbutolol—Alopecia—Fluorouracil—breast cancer	0.00136	0.00163	CcSEcCtD
Penbutolol—Pain—Melphalan—breast cancer	0.00135	0.00163	CcSEcCtD
Penbutolol—Bradycardia—Paclitaxel—breast cancer	0.00133	0.0016	CcSEcCtD
Penbutolol—Nausea—Idarubicin—breast cancer	0.00133	0.0016	CcSEcCtD
Penbutolol—Nausea—Raloxifene—breast cancer	0.00133	0.0016	CcSEcCtD
Penbutolol—Fatigue—Goserelin—breast cancer	0.00133	0.0016	CcSEcCtD
Penbutolol—Pain—Goserelin—breast cancer	0.00132	0.00159	CcSEcCtD
Penbutolol—Asthenia—Chlorambucil—breast cancer	0.0013	0.00156	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Capecitabine—breast cancer	0.00125	0.0015	CcSEcCtD
Penbutolol—Diarrhoea—Chlorambucil—breast cancer	0.00124	0.00149	CcSEcCtD
Penbutolol—Dyspnoea—Vinorelbine—breast cancer	0.00123	0.00148	CcSEcCtD
Penbutolol—Body temperature increased—Goserelin—breast cancer	0.00122	0.00147	CcSEcCtD
Penbutolol—Cough—Irinotecan—breast cancer	0.00122	0.00146	CcSEcCtD
Penbutolol—Cough—Mitoxantrone—breast cancer	0.00122	0.00146	CcSEcCtD
Penbutolol—Asthenia—Vinblastine—breast cancer	0.00119	0.00143	CcSEcCtD
Penbutolol—Depression—Capecitabine—breast cancer	0.00119	0.00143	CcSEcCtD
Penbutolol—Fatigue—Vinorelbine—breast cancer	0.00119	0.00143	CcSEcCtD
Penbutolol—Cough—Gemcitabine—breast cancer	0.00119	0.00143	CcSEcCtD
Penbutolol—Pain—Vinorelbine—breast cancer	0.00118	0.00142	CcSEcCtD
Penbutolol—Dyspepsia—Thiotepa—breast cancer	0.00116	0.0014	CcSEcCtD
Penbutolol—Asthenia—Tamoxifen—breast cancer	0.00116	0.00139	CcSEcCtD
Penbutolol—Alopecia—Paclitaxel—breast cancer	0.00116	0.00139	CcSEcCtD
Penbutolol—Agranulocytosis—Docetaxel—breast cancer	0.00115	0.00139	CcSEcCtD
Penbutolol—Fatigue—Thiotepa—breast cancer	0.00114	0.00137	CcSEcCtD
Penbutolol—Diarrhoea—Vinblastine—breast cancer	0.00114	0.00137	CcSEcCtD
Penbutolol—Asthenia—Melphalan—breast cancer	0.00113	0.00136	CcSEcCtD
Penbutolol—Pain—Thiotepa—breast cancer	0.00113	0.00136	CcSEcCtD
Penbutolol—Agranulocytosis—Capecitabine—breast cancer	0.00112	0.00134	CcSEcCtD
Penbutolol—Asthenia—Goserelin—breast cancer	0.00111	0.00133	CcSEcCtD
Penbutolol—Diarrhoea—Tamoxifen—breast cancer	0.00111	0.00133	CcSEcCtD
Penbutolol—Hyperhidrosis—Irinotecan—breast cancer	0.0011	0.00132	CcSEcCtD
Penbutolol—Hyperhidrosis—Mitoxantrone—breast cancer	0.0011	0.00132	CcSEcCtD
Penbutolol—Dizziness—Vinblastine—breast cancer	0.0011	0.00132	CcSEcCtD
Penbutolol—Mood swings—Methotrexate—breast cancer	0.00109	0.00132	CcSEcCtD
Penbutolol—Bradycardia—Capecitabine—breast cancer	0.00109	0.00131	CcSEcCtD
Penbutolol—Body temperature increased—Vinorelbine—breast cancer	0.00109	0.00131	CcSEcCtD
Penbutolol—Diarrhoea—Melphalan—breast cancer	0.00108	0.0013	CcSEcCtD
Penbutolol—Nausea—Chlorambucil—breast cancer	0.00108	0.0013	CcSEcCtD
Penbutolol—Hyperhidrosis—Gemcitabine—breast cancer	0.00107	0.00129	CcSEcCtD
Penbutolol—Dizziness—Tamoxifen—breast cancer	0.00107	0.00128	CcSEcCtD
Penbutolol—Affect lability—Epirubicin—breast cancer	0.00106	0.00128	CcSEcCtD
Penbutolol—Diarrhoea—Goserelin—breast cancer	0.00106	0.00127	CcSEcCtD
Penbutolol—Body temperature increased—Thiotepa—breast cancer	0.00104	0.00125	CcSEcCtD
Penbutolol—Headache—Vinblastine—breast cancer	0.00104	0.00125	CcSEcCtD
Penbutolol—Insomnia—Irinotecan—breast cancer	0.00103	0.00124	CcSEcCtD
Penbutolol—Mood swings—Epirubicin—breast cancer	0.00102	0.00123	CcSEcCtD
Penbutolol—Dizziness—Goserelin—breast cancer	0.00102	0.00123	CcSEcCtD
Penbutolol—Dyspnoea—Mitoxantrone—breast cancer	0.00102	0.00122	CcSEcCtD
Penbutolol—Dyspnoea—Irinotecan—breast cancer	0.00102	0.00122	CcSEcCtD
Penbutolol—Headache—Tamoxifen—breast cancer	0.00101	0.00122	CcSEcCtD
Penbutolol—Insomnia—Gemcitabine—breast cancer	0.001	0.00121	CcSEcCtD
Penbutolol—Dyspepsia—Mitoxantrone—breast cancer	0.001	0.00121	CcSEcCtD
Penbutolol—Dyspepsia—Irinotecan—breast cancer	0.001	0.00121	CcSEcCtD
Penbutolol—Cough—Paclitaxel—breast cancer	0.000994	0.00119	CcSEcCtD
Penbutolol—Asthenia—Vinorelbine—breast cancer	0.000991	0.00119	CcSEcCtD
Penbutolol—Dyspnoea—Gemcitabine—breast cancer	0.00099	0.00119	CcSEcCtD
Penbutolol—Nausea—Vinblastine—breast cancer	0.000988	0.00119	CcSEcCtD
Penbutolol—Insomnia—Fluorouracil—breast cancer	0.000987	0.00119	CcSEcCtD
Penbutolol—Affect lability—Doxorubicin—breast cancer	0.000985	0.00118	CcSEcCtD
Penbutolol—Fatigue—Mitoxantrone—breast cancer	0.000982	0.00118	CcSEcCtD
Penbutolol—Fatigue—Irinotecan—breast cancer	0.000982	0.00118	CcSEcCtD
Penbutolol—Alopecia—Docetaxel—breast cancer	0.00098	0.00118	CcSEcCtD
Penbutolol—Pain—Mitoxantrone—breast cancer	0.000974	0.00117	CcSEcCtD
Penbutolol—Pain—Irinotecan—breast cancer	0.000974	0.00117	CcSEcCtD
Penbutolol—Dyspnoea—Fluorouracil—breast cancer	0.000973	0.00117	CcSEcCtD
Penbutolol—Headache—Goserelin—breast cancer	0.000966	0.00116	CcSEcCtD
Penbutolol—Dyspepsia—Fluorouracil—breast cancer	0.000961	0.00115	CcSEcCtD
Penbutolol—Nausea—Tamoxifen—breast cancer	0.000959	0.00115	CcSEcCtD
Penbutolol—Fatigue—Gemcitabine—breast cancer	0.000957	0.00115	CcSEcCtD
Penbutolol—Pain—Gemcitabine—breast cancer	0.000949	0.00114	CcSEcCtD
Penbutolol—Alopecia—Capecitabine—breast cancer	0.000949	0.00114	CcSEcCtD
Penbutolol—Mood swings—Doxorubicin—breast cancer	0.000948	0.00114	CcSEcCtD
Penbutolol—Asthenia—Thiotepa—breast cancer	0.000947	0.00114	CcSEcCtD
Penbutolol—Diarrhoea—Vinorelbine—breast cancer	0.000945	0.00114	CcSEcCtD
Penbutolol—Nausea—Melphalan—breast cancer	0.000939	0.00113	CcSEcCtD
Penbutolol—Pain—Fluorouracil—breast cancer	0.000933	0.00112	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Methotrexate—breast cancer	0.000928	0.00112	CcSEcCtD
Penbutolol—Erectile dysfunction—Methotrexate—breast cancer	0.00092	0.00111	CcSEcCtD
Penbutolol—Nausea—Goserelin—breast cancer	0.000916	0.0011	CcSEcCtD
Penbutolol—Dizziness—Vinorelbine—breast cancer	0.000914	0.0011	CcSEcCtD
Penbutolol—Diarrhoea—Thiotepa—breast cancer	0.000903	0.00109	CcSEcCtD
Penbutolol—Body temperature increased—Irinotecan—breast cancer	0.000901	0.00108	CcSEcCtD
Penbutolol—Body temperature increased—Mitoxantrone—breast cancer	0.000901	0.00108	CcSEcCtD
Penbutolol—Hyperhidrosis—Paclitaxel—breast cancer	0.000898	0.00108	CcSEcCtD
Penbutolol—Depression—Methotrexate—breast cancer	0.000888	0.00107	CcSEcCtD
Penbutolol—Propranolol—CYP1A1—breast cancer	0.000878	0.0671	CrCbGaD
Penbutolol—Body temperature increased—Gemcitabine—breast cancer	0.000877	0.00105	CcSEcCtD
Penbutolol—Dizziness—Thiotepa—breast cancer	0.000873	0.00105	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Epirubicin—breast cancer	0.000868	0.00104	CcSEcCtD
Penbutolol—Headache—Vinorelbine—breast cancer	0.000866	0.00104	CcSEcCtD
Penbutolol—Body temperature increased—Fluorouracil—breast cancer	0.000863	0.00104	CcSEcCtD
Penbutolol—Sweating—Methotrexate—breast cancer	0.000853	0.00103	CcSEcCtD
Penbutolol—Cough—Docetaxel—breast cancer	0.000842	0.00101	CcSEcCtD
Penbutolol—Insomnia—Paclitaxel—breast cancer	0.000841	0.00101	CcSEcCtD
Penbutolol—Agranulocytosis—Methotrexate—breast cancer	0.000831	0.000999	CcSEcCtD
Penbutolol—Dyspnoea—Paclitaxel—breast cancer	0.000829	0.000996	CcSEcCtD
Penbutolol—Headache—Thiotepa—breast cancer	0.000827	0.000994	CcSEcCtD
Penbutolol—Nausea—Vinorelbine—breast cancer	0.000821	0.000987	CcSEcCtD
Penbutolol—Dyspepsia—Paclitaxel—breast cancer	0.000818	0.000983	CcSEcCtD
Penbutolol—Asthenia—Irinotecan—breast cancer	0.000818	0.000983	CcSEcCtD
Penbutolol—Asthenia—Mitoxantrone—breast cancer	0.000818	0.000983	CcSEcCtD
Penbutolol—Cough—Capecitabine—breast cancer	0.000815	0.00098	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000803	0.000966	CcSEcCtD
Penbutolol—Fatigue—Paclitaxel—breast cancer	0.000801	0.000963	CcSEcCtD
Penbutolol—Sweating—Epirubicin—breast cancer	0.000799	0.00096	CcSEcCtD
Penbutolol—Asthenia—Gemcitabine—breast cancer	0.000796	0.000957	CcSEcCtD
Penbutolol—Pain—Paclitaxel—breast cancer	0.000795	0.000955	CcSEcCtD
Penbutolol—Nausea—Thiotepa—breast cancer	0.000784	0.000942	CcSEcCtD
Penbutolol—Diarrhoea—Mitoxantrone—breast cancer	0.00078	0.000937	CcSEcCtD
Penbutolol—Diarrhoea—Irinotecan—breast cancer	0.00078	0.000937	CcSEcCtD
Penbutolol—Agranulocytosis—Epirubicin—breast cancer	0.000777	0.000935	CcSEcCtD
Penbutolol—Bradycardia—Epirubicin—breast cancer	0.000761	0.000915	CcSEcCtD
Penbutolol—Diarrhoea—Gemcitabine—breast cancer	0.000759	0.000913	CcSEcCtD
Penbutolol—Dizziness—Irinotecan—breast cancer	0.000754	0.000906	CcSEcCtD
Penbutolol—Diarrhoea—Fluorouracil—breast cancer	0.000747	0.000898	CcSEcCtD
Penbutolol—Sweating—Doxorubicin—breast cancer	0.000739	0.000888	CcSEcCtD
Penbutolol—Hyperhidrosis—Capecitabine—breast cancer	0.000737	0.000886	CcSEcCtD
Penbutolol—Body temperature increased—Paclitaxel—breast cancer	0.000735	0.000883	CcSEcCtD
Penbutolol—Dizziness—Fluorouracil—breast cancer	0.000722	0.000868	CcSEcCtD
Penbutolol—Agranulocytosis—Doxorubicin—breast cancer	0.000719	0.000865	CcSEcCtD
Penbutolol—Headache—Mitoxantrone—breast cancer	0.000714	0.000858	CcSEcCtD
Penbutolol—Headache—Irinotecan—breast cancer	0.000714	0.000858	CcSEcCtD
Penbutolol—Insomnia—Docetaxel—breast cancer	0.000712	0.000856	CcSEcCtD
Penbutolol—Alopecia—Methotrexate—breast cancer	0.000706	0.000849	CcSEcCtD
Penbutolol—Bradycardia—Doxorubicin—breast cancer	0.000704	0.000847	CcSEcCtD
Penbutolol—Dyspnoea—Docetaxel—breast cancer	0.000702	0.000844	CcSEcCtD
Penbutolol—Headache—Gemcitabine—breast cancer	0.000695	0.000836	CcSEcCtD
Penbutolol—Dyspepsia—Docetaxel—breast cancer	0.000693	0.000834	CcSEcCtD
Penbutolol—Insomnia—Capecitabine—breast cancer	0.00069	0.000829	CcSEcCtD
Penbutolol—Headache—Fluorouracil—breast cancer	0.000684	0.000822	CcSEcCtD
Penbutolol—Dyspnoea—Capecitabine—breast cancer	0.00068	0.000817	CcSEcCtD
Penbutolol—Fatigue—Docetaxel—breast cancer	0.000679	0.000816	CcSEcCtD
Penbutolol—Nausea—Mitoxantrone—breast cancer	0.000677	0.000814	CcSEcCtD
Penbutolol—Nausea—Irinotecan—breast cancer	0.000677	0.000814	CcSEcCtD
Penbutolol—Pain—Docetaxel—breast cancer	0.000674	0.00081	CcSEcCtD
Penbutolol—Dyspepsia—Capecitabine—breast cancer	0.000671	0.000807	CcSEcCtD
Penbutolol—Asthenia—Paclitaxel—breast cancer	0.000667	0.000802	CcSEcCtD
Penbutolol—Alopecia—Epirubicin—breast cancer	0.000661	0.000794	CcSEcCtD
Penbutolol—Nausea—Gemcitabine—breast cancer	0.000659	0.000793	CcSEcCtD
Penbutolol—Fatigue—Capecitabine—breast cancer	0.000658	0.00079	CcSEcCtD
Penbutolol—Propranolol—CYP2D6—breast cancer	0.000653	0.05	CrCbGaD
Penbutolol—Pain—Capecitabine—breast cancer	0.000652	0.000784	CcSEcCtD
Penbutolol—Nausea—Fluorouracil—breast cancer	0.000648	0.000779	CcSEcCtD
Penbutolol—Diarrhoea—Paclitaxel—breast cancer	0.000636	0.000764	CcSEcCtD
Penbutolol—Body temperature increased—Docetaxel—breast cancer	0.000623	0.000749	CcSEcCtD
Penbutolol—Dizziness—Paclitaxel—breast cancer	0.000615	0.000739	CcSEcCtD
Penbutolol—Alopecia—Doxorubicin—breast cancer	0.000611	0.000735	CcSEcCtD
Penbutolol—Cough—Methotrexate—breast cancer	0.000607	0.00073	CcSEcCtD
Penbutolol—Body temperature increased—Capecitabine—breast cancer	0.000603	0.000725	CcSEcCtD
Penbutolol—Headache—Paclitaxel—breast cancer	0.000582	0.0007	CcSEcCtD
Penbutolol—Cough—Epirubicin—breast cancer	0.000568	0.000683	CcSEcCtD
Penbutolol—Asthenia—Docetaxel—breast cancer	0.000565	0.000679	CcSEcCtD
Penbutolol—Propranolol—CYP3A4—breast cancer	0.00056	0.0429	CrCbGaD
Penbutolol—Nausea—Paclitaxel—breast cancer	0.000552	0.000664	CcSEcCtD
Penbutolol—Hyperhidrosis—Methotrexate—breast cancer	0.000549	0.00066	CcSEcCtD
Penbutolol—Asthenia—Capecitabine—breast cancer	0.000547	0.000658	CcSEcCtD
Penbutolol—Diarrhoea—Docetaxel—breast cancer	0.000539	0.000648	CcSEcCtD
Penbutolol—Cough—Doxorubicin—breast cancer	0.000526	0.000632	CcSEcCtD
Penbutolol—Diarrhoea—Capecitabine—breast cancer	0.000522	0.000627	CcSEcCtD
Penbutolol—Dizziness—Docetaxel—breast cancer	0.000521	0.000626	CcSEcCtD
Penbutolol—Hyperhidrosis—Epirubicin—breast cancer	0.000514	0.000617	CcSEcCtD
Penbutolol—Insomnia—Methotrexate—breast cancer	0.000514	0.000617	CcSEcCtD
Penbutolol—Dyspnoea—Methotrexate—breast cancer	0.000506	0.000608	CcSEcCtD
Penbutolol—Dizziness—Capecitabine—breast cancer	0.000504	0.000606	CcSEcCtD
Penbutolol—Dyspepsia—Methotrexate—breast cancer	0.0005	0.000601	CcSEcCtD
Penbutolol—Headache—Docetaxel—breast cancer	0.000493	0.000593	CcSEcCtD
Penbutolol—Fatigue—Methotrexate—breast cancer	0.000489	0.000588	CcSEcCtD
Penbutolol—Pain—Methotrexate—breast cancer	0.000486	0.000584	CcSEcCtD
Penbutolol—Insomnia—Epirubicin—breast cancer	0.000481	0.000578	CcSEcCtD
Penbutolol—Headache—Capecitabine—breast cancer	0.000478	0.000574	CcSEcCtD
Penbutolol—Hyperhidrosis—Doxorubicin—breast cancer	0.000475	0.000571	CcSEcCtD
Penbutolol—Dyspnoea—Epirubicin—breast cancer	0.000474	0.000569	CcSEcCtD
Penbutolol—Nausea—Docetaxel—breast cancer	0.000468	0.000562	CcSEcCtD
Penbutolol—Dyspepsia—Epirubicin—breast cancer	0.000468	0.000562	CcSEcCtD
Penbutolol—Propranolol—ABCB1—breast cancer	0.000466	0.0357	CrCbGaD
Penbutolol—Fatigue—Epirubicin—breast cancer	0.000458	0.000551	CcSEcCtD
Penbutolol—Pain—Epirubicin—breast cancer	0.000454	0.000546	CcSEcCtD
Penbutolol—Nausea—Capecitabine—breast cancer	0.000453	0.000545	CcSEcCtD
Penbutolol—Body temperature increased—Methotrexate—breast cancer	0.000449	0.00054	CcSEcCtD
Penbutolol—Insomnia—Doxorubicin—breast cancer	0.000445	0.000535	CcSEcCtD
Penbutolol—Dyspnoea—Doxorubicin—breast cancer	0.000438	0.000527	CcSEcCtD
Penbutolol—Dyspepsia—Doxorubicin—breast cancer	0.000433	0.00052	CcSEcCtD
Penbutolol—Fatigue—Doxorubicin—breast cancer	0.000424	0.00051	CcSEcCtD
Penbutolol—Pain—Doxorubicin—breast cancer	0.00042	0.000505	CcSEcCtD
Penbutolol—Body temperature increased—Epirubicin—breast cancer	0.00042	0.000505	CcSEcCtD
Penbutolol—Asthenia—Methotrexate—breast cancer	0.000407	0.00049	CcSEcCtD
Penbutolol—Body temperature increased—Doxorubicin—breast cancer	0.000389	0.000467	CcSEcCtD
Penbutolol—Diarrhoea—Methotrexate—breast cancer	0.000388	0.000467	CcSEcCtD
Penbutolol—Asthenia—Epirubicin—breast cancer	0.000381	0.000458	CcSEcCtD
Penbutolol—Dizziness—Methotrexate—breast cancer	0.000375	0.000451	CcSEcCtD
Penbutolol—Diarrhoea—Epirubicin—breast cancer	0.000364	0.000437	CcSEcCtD
Penbutolol—Headache—Methotrexate—breast cancer	0.000356	0.000428	CcSEcCtD
Penbutolol—Asthenia—Doxorubicin—breast cancer	0.000353	0.000424	CcSEcCtD
Penbutolol—Dizziness—Epirubicin—breast cancer	0.000351	0.000422	CcSEcCtD
Penbutolol—Nausea—Methotrexate—breast cancer	0.000337	0.000405	CcSEcCtD
Penbutolol—Diarrhoea—Doxorubicin—breast cancer	0.000336	0.000404	CcSEcCtD
Penbutolol—Headache—Epirubicin—breast cancer	0.000333	0.0004	CcSEcCtD
Penbutolol—Dizziness—Doxorubicin—breast cancer	0.000325	0.000391	CcSEcCtD
Penbutolol—Nausea—Epirubicin—breast cancer	0.000316	0.000379	CcSEcCtD
Penbutolol—Headache—Doxorubicin—breast cancer	0.000308	0.00037	CcSEcCtD
Penbutolol—Nausea—Doxorubicin—breast cancer	0.000292	0.000351	CcSEcCtD
Penbutolol—HTR1A—Signaling Pathways—FGF1—breast cancer	3.31e-05	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CSF2—breast cancer	3.31e-05	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—RAF1—breast cancer	3.31e-05	0.000213	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	3.3e-05	0.000213	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NRG1—breast cancer	3.29e-05	0.000212	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—breast cancer	3.27e-05	0.000211	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KIT—breast cancer	3.27e-05	0.000211	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APC—breast cancer	3.27e-05	0.000211	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—H2AFX—breast cancer	3.27e-05	0.000211	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—breast cancer	3.26e-05	0.00021	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SPP1—breast cancer	3.26e-05	0.00021	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	3.24e-05	0.000209	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—E2F1—breast cancer	3.24e-05	0.000209	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGF—breast cancer	3.23e-05	0.000208	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	3.23e-05	0.000208	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	3.22e-05	0.000208	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	3.22e-05	0.000207	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SPP1—breast cancer	3.19e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	3.17e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	3.15e-05	0.000203	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	3.15e-05	0.000203	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK3—breast cancer	3.13e-05	0.000202	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SPP1—breast cancer	3.12e-05	0.000201	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—breast cancer	3.1e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—breast cancer	3.1e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TERT—breast cancer	3.09e-05	0.000199	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB3—breast cancer	3.08e-05	0.000199	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGFR2—breast cancer	3.08e-05	0.000198	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—BRAF—breast cancer	3.07e-05	0.000198	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—breast cancer	3.03e-05	0.000195	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TERT—breast cancer	3.02e-05	0.000195	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	3e-05	0.000193	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—breast cancer	2.99e-05	0.000193	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT2—breast cancer	2.99e-05	0.000193	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—breast cancer	2.98e-05	0.000192	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—breast cancer	2.96e-05	0.000191	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TERT—breast cancer	2.95e-05	0.00019	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	2.95e-05	0.00019	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	2.93e-05	0.000189	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	2.89e-05	0.000186	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—breast cancer	2.88e-05	0.000186	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CD—breast cancer	2.87e-05	0.000185	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGFR1—breast cancer	2.87e-05	0.000185	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CAV1—breast cancer	2.86e-05	0.000184	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—breast cancer	2.84e-05	0.000183	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—breast cancer	2.84e-05	0.000183	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HIF1A—breast cancer	2.82e-05	0.000182	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KDR—breast cancer	2.82e-05	0.000182	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—breast cancer	2.82e-05	0.000182	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—KRAS—breast cancer	2.81e-05	0.000181	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CAV1—breast cancer	2.79e-05	0.00018	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KDR—breast cancer	2.76e-05	0.000178	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—breast cancer	2.76e-05	0.000178	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—breast cancer	2.75e-05	0.000177	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CAV1—breast cancer	2.73e-05	0.000176	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FN1—breast cancer	2.72e-05	0.000175	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—breast cancer	2.71e-05	0.000175	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KDR—breast cancer	2.7e-05	0.000174	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—breast cancer	2.69e-05	0.000174	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	2.69e-05	0.000173	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	2.66e-05	0.000172	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FN1—breast cancer	2.66e-05	0.000171	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—breast cancer	2.63e-05	0.00017	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	2.63e-05	0.000169	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	2.6e-05	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KIT—breast cancer	2.6e-05	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APC—breast cancer	2.6e-05	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	2.6e-05	0.000168	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FN1—breast cancer	2.6e-05	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	2.58e-05	0.000167	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MDM2—breast cancer	2.57e-05	0.000166	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGF—breast cancer	2.57e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKBIA—breast cancer	2.57e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RAF1—breast cancer	2.56e-05	0.000165	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RELA—breast cancer	2.55e-05	0.000165	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APC—breast cancer	2.55e-05	0.000164	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	2.55e-05	0.000164	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KIT—breast cancer	2.55e-05	0.000164	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOTCH1—breast cancer	2.54e-05	0.000164	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ERBB2—breast cancer	2.54e-05	0.000164	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGF—breast cancer	2.52e-05	0.000162	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MTOR—breast cancer	2.5e-05	0.000161	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CB—breast cancer	2.5e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	2.49e-05	0.000161	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APC—breast cancer	2.49e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—breast cancer	2.49e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KIT—breast cancer	2.49e-05	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGF—breast cancer	2.46e-05	0.000159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BRAF—breast cancer	2.45e-05	0.000158	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	2.44e-05	0.000157	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—breast cancer	2.41e-05	0.000155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BRAF—breast cancer	2.39e-05	0.000154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HRAS—breast cancer	2.39e-05	0.000154	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK3—breast cancer	2.38e-05	0.000154	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—breast cancer	2.38e-05	0.000154	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT2—breast cancer	2.38e-05	0.000153	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	2.37e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1B—breast cancer	2.35e-05	0.000151	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BRAF—breast cancer	2.34e-05	0.000151	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—breast cancer	2.33e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT2—breast cancer	2.33e-05	0.00015	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—breast cancer	2.32e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	2.32e-05	0.00015	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—breast cancer	2.3e-05	0.000148	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—breast cancer	2.3e-05	0.000148	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—breast cancer	2.29e-05	0.000147	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	2.29e-05	0.000147	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—breast cancer	2.28e-05	0.000147	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT2—breast cancer	2.28e-05	0.000147	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—breast cancer	2.27e-05	0.000146	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	2.27e-05	0.000146	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	2.26e-05	0.000146	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCND1—breast cancer	2.24e-05	0.000144	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	2.24e-05	0.000144	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	2.24e-05	0.000144	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JUN—breast cancer	2.24e-05	0.000144	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CTNNB1—breast cancer	2.22e-05	0.000143	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	2.22e-05	0.000143	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	2.21e-05	0.000143	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	2.19e-05	0.000141	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CD—breast cancer	2.19e-05	0.000141	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—breast cancer	2.18e-05	0.00014	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1A—breast cancer	2.17e-05	0.00014	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	2.17e-05	0.00014	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—breast cancer	2.16e-05	0.00014	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTEN—breast cancer	2.16e-05	0.000139	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—breast cancer	2.16e-05	0.000139	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—KRAS—breast cancer	2.14e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK8—breast cancer	2.12e-05	0.000136	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—breast cancer	2.11e-05	0.000136	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—breast cancer	2.11e-05	0.000136	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—breast cancer	2.07e-05	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	2.06e-05	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MDM2—breast cancer	2.05e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RAF1—breast cancer	2.04e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RELA—breast cancer	2.03e-05	0.000131	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	2.02e-05	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	2.01e-05	0.00013	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SRC—breast cancer	2.01e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MDM2—breast cancer	2e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RAF1—breast cancer	2e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MTOR—breast cancer	1.99e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.99e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RELA—breast cancer	1.99e-05	0.000128	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	1.98e-05	0.000127	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.97e-05	0.000127	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MDM2—breast cancer	1.96e-05	0.000126	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—breast cancer	1.95e-05	0.000126	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RAF1—breast cancer	1.95e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MTOR—breast cancer	1.95e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	1.95e-05	0.000126	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RELA—breast cancer	1.94e-05	0.000125	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—breast cancer	1.93e-05	0.000125	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.93e-05	0.000125	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.92e-05	0.000124	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MTOR—breast cancer	1.91e-05	0.000123	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.91e-05	0.000123	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.9e-05	0.000123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.87e-05	0.000121	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.87e-05	0.000121	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.86e-05	0.00012	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.85e-05	0.000119	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK3—breast cancer	1.85e-05	0.000119	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—breast cancer	1.83e-05	0.000118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.83e-05	0.000118	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—breast cancer	1.83e-05	0.000118	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.83e-05	0.000118	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—breast cancer	1.82e-05	0.000117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.82e-05	0.000117	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.81e-05	0.000117	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—breast cancer	1.8e-05	0.000116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—breast cancer	1.79e-05	0.000116	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.79e-05	0.000116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—breast cancer	1.79e-05	0.000115	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.79e-05	0.000115	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCND1—breast cancer	1.78e-05	0.000115	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—breast cancer	1.78e-05	0.000115	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JUN—breast cancer	1.78e-05	0.000115	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.77e-05	0.000114	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.77e-05	0.000114	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—breast cancer	1.76e-05	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—breast cancer	1.75e-05	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—breast cancer	1.75e-05	0.000113	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCND1—breast cancer	1.75e-05	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—breast cancer	1.74e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JUN—breast cancer	1.74e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—breast cancer	1.73e-05	0.000112	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.73e-05	0.000111	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.73e-05	0.000111	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTEN—breast cancer	1.72e-05	0.000111	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCND1—breast cancer	1.71e-05	0.00011	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JUN—breast cancer	1.7e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—breast cancer	1.7e-05	0.000109	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.69e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.69e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.69e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTEN—breast cancer	1.69e-05	0.000109	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.68e-05	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KRAS—breast cancer	1.66e-05	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—breast cancer	1.66e-05	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.65e-05	0.000106	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.65e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTEN—breast cancer	1.65e-05	0.000106	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.64e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.61e-05	0.000104	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.61e-05	0.000104	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SRC—breast cancer	1.6e-05	0.000103	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SRC—breast cancer	1.56e-05	0.000101	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.56e-05	0.0001	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—breast cancer	1.54e-05	9.93e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SRC—breast cancer	1.53e-05	9.85e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.53e-05	9.84e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.52e-05	9.81e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—breast cancer	1.51e-05	9.72e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.49e-05	9.6e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TP53—breast cancer	1.48e-05	9.52e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—breast cancer	1.47e-05	9.5e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.47e-05	9.49e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.44e-05	9.28e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—breast cancer	1.43e-05	9.23e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.43e-05	9.21e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HRAS—breast cancer	1.41e-05	9.1e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.41e-05	9.08e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—breast cancer	1.4e-05	9.03e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—breast cancer	1.4e-05	9.03e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.4e-05	9.01e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—breast cancer	1.37e-05	8.83e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—breast cancer	1.37e-05	8.83e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.37e-05	8.81e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—breast cancer	1.35e-05	8.71e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—breast cancer	1.34e-05	8.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KRAS—breast cancer	1.32e-05	8.53e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KRAS—breast cancer	1.29e-05	8.34e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KRAS—breast cancer	1.27e-05	8.16e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—breast cancer	1.25e-05	8.04e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.22e-05	7.84e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.19e-05	7.67e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TP53—breast cancer	1.18e-05	7.58e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.16e-05	7.5e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TP53—breast cancer	1.15e-05	7.42e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TP53—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HRAS—breast cancer	1.12e-05	7.25e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HRAS—breast cancer	1.1e-05	7.09e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—breast cancer	1.08e-05	6.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HRAS—breast cancer	1.08e-05	6.93e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—breast cancer	1.05e-05	6.79e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—breast cancer	1.03e-05	6.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—breast cancer	9.93e-06	6.4e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—breast cancer	9.71e-06	6.26e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—breast cancer	9.5e-06	6.12e-05	CbGpPWpGaD
